Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

Schatz RA.

Ann Pharmacother. 2003 Sep;37(9):1321-4. Review.

PMID:
12921516
2.

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.

Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2000 Oct;57(10):968-76.

PMID:
11015815
3.
4.

Use of olanzapine for elderly patients with psychotic disorders: a review.

Madhusoodanan S, Sinha S, Brenner R, Gupta S, Bogunovic O.

Ann Clin Psychiatry. 2001 Dec;13(4):201-13. Review.

PMID:
11958362
5.

Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia.

Street JS, Clark WS, Kadam DL, Mitan SJ, Juliar BE, Feldman PD, Breier A.

Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S62-70.

PMID:
11748789
6.

Olanzapine in whole, not half, tablets for psychosis from Alzheimer's dementia.

Wolfgang SA.

Am J Health Syst Pharm. 1999 Nov 1;56(21):2245-6. No abstract available.

PMID:
10565707
7.

Olanzapine for schizophrenia.

Duggan L, Fenton M, Dardennes RM, El-Dosoky A, Indran S.

Cochrane Database Syst Rev. 2003;(1):CD001359. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD001359.

PMID:
12535408
8.

Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.

Marsh L, Lyketsos C, Reich SG.

Psychosomatics. 2001 Nov-Dec;42(6):477-81.

PMID:
11815682
9.

Olanzapine and the new generation of antipsychotic agents: patterns of use.

Glazer WM.

J Clin Psychiatry. 1997;58 Suppl 10:18-21. Review.

10.

The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.

Clark WS, Street JS, Feldman PD, Breier A.

J Clin Psychiatry. 2001 Jan;62(1):34-40.

PMID:
11235926
11.

An open trial of olanzapine in the treatment of patients with psychotic depression.

Nelson EB, Rielage E, Welge JA, Keck PE Jr.

Ann Clin Psychiatry. 2001 Sep;13(3):147-51.

PMID:
11791952
12.

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.

Schneider LS, Tariot PN, Lyketsos CG, Dagerman KS, Davis KL, Davis S, Hsiao JK, Jeste DV, Katz IR, Olin JT, Pollock BG, Rabins PV, Rosenheck RA, Small GW, Lebowitz B, Lieberman JA.

Am J Geriatr Psychiatry. 2001 Fall;9(4):346-60.

PMID:
11739062
13.

A case of monosymptomatic hypochondriacal psychosis treated with olanzapine.

Weintraub E, Robinson C.

Ann Clin Psychiatry. 2000 Dec;12(4):247-9.

PMID:
11140927
14.

The management of psychogeriatric patient.

Zannino G, Gargiulo A, Lamenza F, Marotta MG, Barzotti T, Silvestri A, Ettorre E, Marigliano V.

Arch Gerontol Geriatr Suppl. 2004;(9):465-70.

PMID:
15207448
15.

Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.

Cummings JL, Street J, Masterman D, Clark WS.

Dement Geriatr Cogn Disord. 2002;13(2):67-73.

PMID:
11844887
16.

The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

Ballard C, Waite J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003476. Review.

PMID:
16437455
17.

Use of high-dose olanzapine in refractory psychosis.

Reich J.

Am J Psychiatry. 1999 Apr;156(4):661. No abstract available.

PMID:
10200755
18.

Olanzapine and negative symptoms.

Rosen EH.

J Clin Psychiatry. 1998 Oct;59(10):537-8. No abstract available.

PMID:
9818636
19.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group..

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
20.

Open-label olanzapine treatment in five preadolescent children.

Krishnamoorthy J, King BH.

J Child Adolesc Psychopharmacol. 1998;8(2):107-13.

PMID:
9730076
Items per page

Supplemental Content

Support Center